Clinical Trial Update: A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 long-term safety and efficacy study evaluating APG777 for atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• APG777

Snippet

Sponsor: Apogee Therapeutics, Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING